.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Accenture
Moodys
Federal Trade Commission
Citi
Julphar
Teva
Chubb
Harvard Business School
Mallinckrodt

Generated: September 26, 2017

DrugPatentWatch Database Preview

MEDIHALER-EPI Drug Profile

« Back to Dashboard

Which patents cover Medihaler-epi, and when can generic versions of Medihaler-epi launch?

Medihaler-epi is a drug marketed by 3M and is included in one NDA.

The generic ingredient in MEDIHALER-EPI is epinephrine bitartrate. There are nineteen drug master file entries for this compound. Additional details are available on the epinephrine bitartrate profile page.

Summary for Tradename: MEDIHALER-EPI

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list55
Clinical Trials: see list108
Patent Applications: see list508
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MEDIHALER-EPI at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m
MEDIHALER-EPI
epinephrine bitartrate
AEROSOL, METERED;INHALATION010374-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Cipla
Mallinckrodt
Fuji
Moodys
Covington
Cerilliant
Deloitte
US Army
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot